Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

LCID Stock Alert: Watch This KEY Lawsuit News

By Dana Blankenhorn, InvestorPlace Contributor

Lucid Motors won the dismissal of an investor suit and is funded through 2024. The challenge for LCID stock now is Lucid's profitability.

BBBY Stock Alert: Will a Short Squeeze Keep Bed Bath & Beyond From Bankruptcy?

By Dana Blankenhorn, InvestorPlace Contributor

The ability of small investors to squeeze institutions that short stocks may dissuade some from betting on disaster with BBBY stock.

Virgin Orbit (VORB) Stock Plunges 20% on Rocket Failure

By Dana Blankenhorn, InvestorPlace Contributor

Virgin Orbit may need more cash to get its plane-based launch system off the ground after its rocket failed, sending VORB stock down.

Dear SOFI Stock Fans, Mark Your Calendars for Jan. 30

By Dana Blankenhorn, InvestorPlace Contributor

SOFI stock investors should watch out for Jan. 30 as the fintech company is expected to report its full-year results for 2022.

Why Is Ocugen (OCGN) Stock Up Today?

By Dana Blankenhorn, InvestorPlace Contributor

Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines.

Legendary Investor Bill Miller Is Betting Big Against Tesla (TSLA) Stock

By Dana Blankenhorn, InvestorPlace Contributor

Miller insists Tesla can't be worth more than the 5 largest car companies combined, and the company does face more competition.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

Dear HKD Stock Fans, Mark Your Calendars for Jan. 11

By Dana Blankenhorn, InvestorPlace Contributor

HKD stock continued its rise overnight, but there's still not much to the company justifying anything like a $5.6 billion market cap.

Is Bed Bath & Beyond (BBBY) Stock About to Die?

By Dana Blankenhorn, InvestorPlace Contributor

Former meme favorite Bed Bath & Beyond warned it may not survive, and other retail stocks may follow down bankruptcy road.

Why Is AMTD Digital (HKD) Stock Up 80% Today?

By Dana Blankenhorn, InvestorPlace Contributor

The third short squeeze in HKD stock is unlikely to last any longer than the previous two, as there is no news to justify its major rise.

Load More